Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors
Summary
Appointment strengthens Board’s clinical development and regulatory expertise as Vaxart advances its oral vaccine platform
Description
Appointment strengthens Board’s clinical development and regulatory expertise as Vaxart advances its oral vaccine platform
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source